Search

Your search keyword '"Carlos M. Luna"' showing total 270 results

Search Constraints

Start Over You searched for: Author "Carlos M. Luna" Remove constraint Author: "Carlos M. Luna"
270 results on '"Carlos M. Luna"'

Search Results

1. Impact of Age, Comorbidities and Complications in COVID-19 Patients with Acute Respiratory Distress Syndrome on Invasive Mechanical Ventilation. An Observational Multicenter Study

2. Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms

3. Respiratory viruses: their importance and lessons learned from COVID-19

4. Design and Rationale of a Prospective International Follow-Up Study on Intensive Care Survivors of COVID-19: The Long-Term Impact in Intensive Care Survivors of Coronavirus Disease-19–AFTERCOR

5. Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020)

6. Decreased relative risk of pneumococcal pneumonia during the last decade, a nested case-control study

7. Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study

9. Gram-Negative Infections in Adult Intensive Care Units of Latin America and the Caribbean

10. Correction: ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia

11. Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19

13. Updated Strategic Plan of the Latin American Thoracic Association (ALAT). 'The ten commandments for 2021–2026 quinquennial'

14. Actualización del Plan Estratégico de la Asociación Latinoamericana de Tórax (ALAT). «Los diez mandamientos para el quinquenio 2021-2026»

15. Understanding the Host in the Management of Pneumonia. An Official American Thoracic Society Workshop Report

16. Author response for 'Symptom‐based case definitions for COVID‐19: Time and geographical variations for detection at hospital admission among 260,000 patients'

17. International Perspective on the New 2019 American Thoracic Society/Infectious Diseases Society of America Community-Acquired Pneumonia Guideline

18. Treatment of Community-Acquired Pneumonia in Immunocompromised Adults

19. Assessment of 28-day in-hospital mortality in mechanically ventilated patients with coronavirus disease 2019: an international cohort study

20. Immunizations in adults with cardiovascular disease. Summary of the Consensus of the Argentine Cardiology Society

21. Updated guidance on the management of COVID-19: From an american thoracic society/european respiratory society coordinated international task force (29 July 2020)

22. Incidence and Mortality of Adults Hospitalized With Community-Acquired Pneumonia According to Clinical Course

23. Never Let a Good Crisis Go to Waste

24. Tuberculosis/SARS-CoV-2 Co-infection: a Case Series

25. COVID-19 pneumonia and clinical follow-up: results of a prospective cohort

26. Risk Factors for 28-Day in-Hospital Mortality in Mechanically Ventilated Patients with COVID-19: An International Cohort Study

27. The value of open-source clinical science in pandemic response

28. Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia

29. Can lactate dehydrogenase (LDH) be used as a marker of severity of pneumonia in patients with renal transplant?

30. International Perspective on the New 2019 American Thoracic Society/Infectious Diseases Society of America Community-Acquired Pneumonia Guideline: A Critical Appraisal by a Global Expert Panel

31. Why is the rate of pneumococcal pneumonia declining?

32. Transformer model with saturation effects for frequency‐domain transients simulation

33. Bilateral diaphragmatic paralysis after an unusual physical effort

34. Bacteremic pneumococcal pneumonia is associated with an increased rate of cardiovascular events

35. Score for Differentiating Pleural Tuberculosis from Malignant Effusion

36. Do we need biomarkers for the follow-up and shortening of antibiotic treatment duration?

37. The Cefazolin Inoculum Effect Is Associated With Increased Mortality in Methicillin-Susceptible Staphylococcus aureus Bacteremia

38. Erratum for Arias et al., 'A Prospective Cohort Multicenter Study of Molecular Epidemiology and Phylogenomics of Staphylococcus aureus Bacteremia in Nine Latin American Countries'

39. Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia

40. 2176. A New Rapid Test for Detection of The Cefazolin Inoculum Effect (CIE) in Methicillin-Susceptible Staphylococcus aureus (MSSA)

41. Does animal model on ventilator-associated pneumonia reflect physiopathology of sepsis mechanisms in humans?

42. Outcomes in patients with community-acquired pneumonia admitted to the intensive care unit

43. Short duration of antibiotic therapy in hospitalized patients with community-acquired pneumonia: results from the CAPO International Cohort Study

44. A prospective cohort multicenter study of molecular epidemiology and phylogenomics of Staphylococcus aureus bacteremia in nine Latin American countries

45. Community-Acquired Pneumonia in Latin America

46. Is a Strategy Based on Routine Endotracheal Cultures the Best Way to Prescribe Antibiotics in Ventilator-Associated Pneumonia?

47. The Impact of Age and Comorbidities on the Mortality of Patients of Different Age Groups Admitted with Community-acquired Pneumonia

48. Characterization and Clinical Impact of Bloodstream Infection Caused by Carbapenemase-Producing Enterobacteriaceae in Seven Latin American Countries

49. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study

50. Impacto de la bacteriemia en una cohorte de pacientes con neumonía neumocócica Impact of bacteremia in a cohort of patients with pneumococcal pneumonia

Catalog

Books, media, physical & digital resources